NCT00800579View on ClinicalTrials.gov

Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Cystic Fibrosis

Interventions

DRUG

GS-9411

Inhaled GS-9411 dissolved in sterile saline

DRUG

Placebo

Inhaled volume-matched placebo in sterile saline

Trial Locations (1)

3004

Nucleus Network Ltd., Melbourne

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY

NCT00800579 - Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter